Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes Trial

David Linetsky
Point-of-Care Marketing

Harshit Jain, MD
Programmatic Marketing

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition